SCD and cancer: Taken together, these results suggest that SCD inhibition causes alterations in the composition of lipids that are crucial for the function of the inner mitochondrial membrane and that altered lipid desaturation can enhance the susceptibility of cancer cells towards chemotherapeutic drugs and metabolic inhibitors.